Home » Topics » BioWorld Science

BioWorld Science
RSS

First-in-human results presented for SBC-103 in children with MPS IIIB

Feb. 13, 2018

Cancer Targeted Technology, Advanced Accelerator Applications enter CTT-1057 license agreement

Feb. 13, 2018

Shire's SHP-647 granted orphan drug status for Crohn's disease in pediatric population

Feb. 13, 2018

SGSH gene therapy shows biological activity in phase I/II MPS type III A trial

Feb. 13, 2018

FDA approves Icon Bioscience's Dexycu for inflammation associated with cataract surgery

Feb. 13, 2018

Inovio Pharmaceuticals and The Wistar Institute to jointly develop vaccines for TB and malaria

Feb. 13, 2018

FDA grants priority review to migalastat NDA

Feb. 13, 2018

Dare Bioscience obtains license to Strategic Science & Technologies' SST-6007

Feb. 13, 2018

FDA awards orphan drug status to Abeona's ABO-202

Feb. 13, 2018

Vyera initiates phase I study of TUR-006 as treatment for toxoplasmosis

Feb. 13, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...